Twist Bioscience stock surges to 92.15 after strong buying momentum and elevated technicals

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience surges 8.41% today

Highlights

TWST exhibits strong bullish momentum, trading significantly above all major moving averages and consolidating near weekly highs.
Momentum and trend indicators confirm a robust uptrend, with buying pressure dominating and limited signs of reversal despite an overbought reading.
For the coming week, TWST is expected to trade within a broad $83.00–$100.00 range, with breakout potential above $100.00 and minimal downside risk.

Twist Bioscience expressed gratitude to the authors for selecting its DNA products in this work. The study was published in Scientific Reports.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish momentum confirmed as price holds above all key moving averages

TWST is trading well above major moving averages, with the current price of $92.15 standing significantly above the MA-20 at $74.14, MA-50 at $63.93, and MA-200 at $43.78. This alignment confirms strong bullish momentum across short, medium, and long-term trends. The Ichimoku Kijun level on D1 sits at $68.87, marking immediate support below current prices. Near-term support is seen at the Kijun ($68.87), with key support at MA-50 ($63.93). Near-term resistance sits at MA-5 ($85.11), with key resistance at MA-20 ($74.14), though these are both currently well beneath the market, highlighting the lack of nearby overhead resistance.

Strong upside momentum as indicators approach overbought territory

Momentum remains robust, with both MACD and ADX on D1 signaling a strong buy. RSI is elevated at 69.57 and CCI reads 109.03, suggesting the asset is approaching overbought levels, while Stoch RSI is neutral. BBP indicates clear buyer dominance, corroborating the strong uptrend, while the Awesome Oscillator also supports continued bullish momentum. In today's session, TWST has jumped 8.41%, reflecting fresh buying interest and pushing the price to the top of the weekly range. Over the past week, the stock has risen $4.59 (5.31%) from a previous close of $87.56, with weekly volatility at 10.01%. The tone remains bullish, with price action consolidating near resistance and no signs yet of a reversal.

High upside probability as bullish signals outweigh limited downside risk

For the coming week, the expected trading range is adjusted to $83.00–$100.00, keeping the forecast within a realistic band around the current price; this range is near the top end of the 52-week spectrum of $23.30–$89.71. Bullish signals dominate across W1 indicators: RSI, ADX, MACD, and MA-50 all show "Buy", resulting in a very high probability (more than 80%) of upside continuation, with downside risk considered very low. The baseline scenario anticipates continued consolidation or sideways action within the range. A bullish breakout above $100.00 could trigger further upside as buyers remain in control. Conversely, a drop below $83.00 could open a retracement phase, but the probability of significant downside appears limited given the current technical setup.

Earlier, analysts noted that Twist Bioscience exhibited firm bullish momentum across multiple timeframes, with technical signals favoring continued consolidation following substantial gains. This article adds new context for traders by outlining the current scenario and highlighting a key level to watch as sentiment and momentum indicators evolve.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.